Your browser doesn't support javascript.
loading
Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.
Kosmidis, Chris; Rodriguez-Goncer, Isabel; Rautemaa-Richardson, Riina; Richardson, Malcolm D; Moore, Caroline B; Denning, David W.
Afiliação
  • Kosmidis C; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Rodriguez-Goncer I; National Aspergillosis Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Southmoor Road, Manchester, UK.
  • Rautemaa-Richardson R; National Aspergillosis Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Southmoor Road, Manchester, UK.
  • Richardson MD; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Moore CB; National Aspergillosis Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Southmoor Road, Manchester, UK.
  • Denning DW; Mycology Reference Centre Manchester, ECMM Centre of Excellence, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK.
J Antimicrob Chemother ; 74(4): 1056-1061, 2019 04 01.
Article em En | MEDLINE | ID: mdl-30590533

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triazóis / Aspergilose Pulmonar / Antifúngicos Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triazóis / Aspergilose Pulmonar / Antifúngicos Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019